MAOIs vs placebo
Withdrawals due to adverse events · patients with fibromyalgia
1 finding from 1 review
- Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome 2012 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 149 participantsLow